Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 1.424% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
(a) Cn1c(=O)c2sccc2n2c(CCCC(=O)NCc3cccnc3)nnc12
(b) CCCN(C(=O)COC(=O)C12CCC(=O)N1c1ccccc1S2)c1c(N)n(Cc2ccccc2)c(=O)[nH]c1=O
(c) COc1ccc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)sc2c1
(d) Nn1cc(-c2ccccc2)nc1SCC(=O)NCC1CCCO1
(e) CC1(C(=O)O)C2C=CC(C2)C1C(=O)NCc1ccccc1
Answer: d. Nn1cc(-c2ccccc2)nc1SCC(=O)NCC1CCCO1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Nn1cc(-c2ccccc2)nc1SCC(=O)NCC1CCCO1
Nn1cc(-c2ccccc2)nc1SCC(=O)NCC1CCCO1
2-(1-amino-4-phenylimidazol-2-yl)sulfanyl-N-(oxolan-2-ylmethyl)acetamide